The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Cannabis Use in HIV for Pain and Other Medical Symptoms
Open accessAbstract
Despite the major benefits of antiretroviral therapy on survival during HIV infection, there is an increasing need to manage symptoms and side effects during long-term drug therapy. Cannabis has been reported anecdotally as being beneficial for a number of common symptoms and complications in HIV infections, for example, poor appetite and neuropathy. This study aimed to investigate symptom management with cannabis. Following Ethics Committee approval, HIV-positive individuals attending a large clinic were recruited into an anonymous cross-sectional questionnaire study. Up to one-third (27%, 143/523) reported using cannabis for treating symptoms. Patients reported improved appetite (97%), muscle pain (94%), nausea (93%), anxiety (93%), nerve pain (90%), depression (86%), and paresthesia (85%). Many cannabis users (47%) reported associated memory deterioration. Symptom control using cannabis is widespread in HIV outpatients. A large number of patients reported that cannabis improved symptom control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Each study involved whole plant cannabis in inhaled or oral formats, with patients reporting moderate relief.”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [88]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An anonymous cross-sectional questionnaire study revealed that as many as one-third of patients suffering from HIV have used cannabis to treat symptoms.138”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [138]
The cited source says what the claim attributes to it.
In the citing paper
“Three cross-sectional studies also report antidepressant effects of CBM.82,97,98”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [97]
In the citing paper
“Among the symptoms improved following cannabis were appetite (97% reported improvement), pain (improved in 94% of the patients with pain), nausea (93% reported improvement) and anxiety (93% reported improvement).138”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V., Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A. N., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,269
Adverse effects of antiretroviral therapy
Carr, A. D., & Cooper, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02854-3 · Cited by 1,076
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 825
Iversen, L. L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 751
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
An analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C. A., Petzold, A., Thompson, A. J., Giovannoni, G., et al. (2003) · Brain · doi:10.1093/brain/awg224 · Cited by 345
Research works printed but not linked: 1
- Prestage GS, Kippax S, Grulich A. Use of treatments and health enhancement behaviours among HIV positive men in a cohort of homosexually active men. XI International Conference on AIDS, Vancouver, BC, Canada, July 1996. Abstract thD 5181.
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 692
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Pain and Depression: A Systematic Review
IsHak, W. W., Wen, R. Y., Naghdechi, L., Vanle, B., Dang, J., Knosp, M., Dascal, J., Marcia, L., Gohar, Y., Eskander, L., et al. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000198 · Cited by 498
Cannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305
Buckner, J. D., Keough, M. E., & Schmidt, N. B. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.12.019 · Cited by 301
Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.587700 · Cited by 290
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., Abrams, D. I., Prasad, H., Wilsey, B. L., Indyk, D., et al. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.07.009 · Cited by 268
Phillips, T., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014433 · Cited by 257
Medical cannabis and mental health: A guided systematic review
Walsh, Z., González, R., Crosby, K., Thiessen, M. S., Carroll, C., & Bonn‐Miller, M. O. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.002 · Cited by 260
Cannabinoids in health and disease
Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 227
Storr, M., Devlin, S. M., Kaplan, G. G., Panaccione, R., & Andrews, C. N. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440982.79036.d6 · Cited by 207
Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 219
Modulation of pain transmission by G-protein-coupled receptors
Pan, H., Wu, Z.-Z., Zhou, H.-Y., Chen, S.-R., Zhang, H., & Li, D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.003 · Cited by 204
Substance use: impact on adherence and HIV medical treatment
Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0093-5 · Cited by 195
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184
Cannabis use amongst patients with inflammatory bowel disease
Lal, S., Prasad, N., Ryan, M., Tangri, S., Silverberg, M. S., GORDON, A. S., & Steinhart, H. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328349bb4c · Cited by 170
The molecular neurobiology of chronic pain–induced depression
Humo, M., Lu, H., & Yalçın, İ. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03003-z · Cited by 167
The analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours
Pacula, R. L., Jacobson, M., & Hernandez, E. J. M. (2015) · Addiction · doi:10.1111/add.13282 · Cited by 138
Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.
Bonn‐Miller, M. O., Harris, A. H. S., & Trafton, J. A. (2012) · Psychological Services · doi:10.1037/a0027622 · Cited by 135
Endocannabinoid system: Role in depression, reward and pain control (Review)
Huang, W., Chen, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5585 · Cited by 139
Kramer, J. L. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21260 · Cited by 138
Stigma among California’s Medical Marijuana Patients
Satterlund, T. D., Lee, J. P., & Moore, R. S. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.991858 · Cited by 129
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
Spire, B., Lucas, G. M., & Carrieri, P. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.12.014 · Cited by 125
Littlewood, R. A., & Vanable, P. A. (2008) · AIDS Care · doi:10.1080/09540120701767216 · Cited by 120
Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
Allegretti, J. R., Courtwright, A., Lucci, M., Korzenik, J. R., & LEVINE, J. S. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435851.94391.37 · Cited by 119
Krolick, K. N., Zhu, Q., & Shi, H. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.07.008 · Cited by 126
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108
Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms
Bonn‐Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9458-5 · Cited by 99
Bruce, R. D., Merlin, J. S., Lum, P. J., Ahmed, E., Alexander, C. S., Corbett, A., Foley, K. M., Leonard, K., Treisman, G. J., & Selwyn, P. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix636 · Cited by 94
DʼSouza, G., Matson, P. A., Grady, C. D., Nahvi, S., Merenstein, D., Weber, K. M., Greenblatt, R. M., Burian, P., & Wilson, T. E. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318273ab3a · Cited by 86
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
Weiss, A., & Friedenberg, F. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.035 · Cited by 85
Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
Hazekamp, A., & Heerdink, E. R. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1503-y · Cited by 81
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Bedi, G., Foltin, R. W., Gunderson, E. W., Rabkin, J. G., Hart, C. L., Comer, S. D., Vosburg, S. K., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1995-4 · Cited by 77
Bell, A. D., MacCallum, C., Margolese, S., Walsh, Z., Wright, P., Daeninck, P. J., Mandarino, E., Lacasse, G., Kaur Deol, J., de Freitas, L., et al. (2024) · Cannabis & Cannabinoid Research · doi:10.1089/can.2021.0156 · Cited by 78
“60 Three cross-sectional studies also report antidepressant effects of CBM. 82,97,98 Studies involving the use of cannabis extracts are generally less positive regarding the benefits of CBM for treating depression in people with chronic pain.”
BackgroundHerbal medicinal products or preparations for neuropathic pain
Boyd, A., Bleakley, C., Hurley, D. A., Gill, C. I. R., Hannon-Fletcher, M. P. A., Bell, P., & McDonough, S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010528.pub4 · Cited by 74
Symptom management and self-care for peripheral neuropathy in HIV/AIDS
Nicholas, P. K., Kemppainen, J. K., Canaval, G. E., Corless, I. B., Sefcik, E. F., Nokes, K. M., Bain, C. A., Kirksey, K. M., Eller, L. S., Dole, P. J., et al. (2007) · AIDS Care · doi:10.1080/09540120600971083 · Cited by 72
Cannabinoid control of neuroinflammation related to multiple sclerosis
Baker, D., Jackson, S. J., & Pryce, G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707458 · Cited by 69
Watson, C. W., Paolillo, E. W., Morgan, E. E., Umlauf, A., Sundermann, E. E., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Heaton, R. K., & Grant, I. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002211 · Cited by 66
The Link between Cannabis Use, Immune System, and Viral Infections
Maggirwar, S. B., & Khalsa, J. H. (2021) · Viruses · doi:10.3390/v13061099 · Cited by 67
Effects of cannabinoids and their receptors on viral infections
Tahamtan, A., Tavakoli‐Yaraki, M., Rygiel, T. P., Mokhtari‐Azad, T., & Salimi, V. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24292 · Cited by 66
New Treatments for Neuropathic Pain
Rice, A. S. C., & Hill, R. G. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131324 · Cited by 65
Analysis of Factors Influencing the Ultrasonic Fetal Weight Estimation
Heer, I. M., Kümper, C., Vögtle, N., Müller-Egloff, S., Dugas, M., & Strauss, A. S. (2008) · Fetal Diagnosis and Therapy · doi:10.1159/000116742 · Cited by 63
Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine
Kruger, D. J., & Kruger, J. S. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1563314 · Cited by 61
Cannabis use in sickle cell disease: a questionnaire study
Howard, J., Anie, K. A., Holdcroft, A., Israeli‐Korn, S., & Davies, S. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05723.x · Cited by 61
Self-citationIs cannabis use associated with less opioid use among people who inject drugs?
Kral, A. H., Wenger, L. D., Novak, S. P., Chu, D., Corsi, K. F., Coffa, D. A., Shapiro, B. J., & Bluthenthal, R. N. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.014 · Cited by 58
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 60
Meade, C. S., Drabkin, A. S., Hansen, N. B., Wilson, P. A., Kochman, A., & Sikkema, K. J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03075.x · Cited by 57
Electrochemical sensing: A prognostic tool in the fight against COVID-19
Kotru, S., Klimuntowski, M., Ridha, H., Uddin, Z., Askhar, A. A., Singh, G., & Howlader, M. M. R. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116198 · Cited by 57
Weber, J., Schley, M. T., Casutt, M., Gerber, H., Schuepfer, G., Rukwied, R., Schleinzer, W., Ueberall, M. A., & Konrad, C. J. (2009) · Anesthesiology Research and Practice · doi:10.1155/2009/827290 · Cited by 56
The Association Between Marijuana Use and HIV Continuum of Care Outcomes: a Systematic Review
Montgomery, L., Bagot, K. S., Brown, R., & Haeny, A. M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00422-z · Cited by 56
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
Inglet, S., Winter, B., Yost, S. E., Entringer, S., Lian, A., Biksacky, M., Pitt, R. D., & Mortensen, W. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020930189 · Cited by 56
Sex differences in cannabinoid-regulated biology: A focus on energy homeostasis
Wagner, E. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.01.003 · Cited by 54
Marijuana Effectiveness as an HIV Self-Care Strategy
Corless, I. B., Lindgren, T. G., Holzemer, W. L., Robinson, L. L., Moezzi, S., Kirksey, K. M., Coleman, C. L., Tsai, Y., Eller, L. S., Hamilton, M. J., et al. (2009) · Clinical Nursing Research · doi:10.1177/1054773809334958 · Cited by 50
HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads
Borgmann, K., & Ghorpade, A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01143 · Cited by 51
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV− adults
Thames, A. D., Kuhn, T. P., Williamson, T. J., Jones, J. D., Mahmood, Z., & Hammond, A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.007 · Cited by 52
Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV
Watson, C. W., Campbell, L. M., Sun-Suslow, N., Hong, S., Umlauf, A., Ellis, R. J., Iudicello, J. E., Letendre, S. L., Marcotte, T. D., Heaton, R. K., et al. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720001447 · Cited by 49
Slawson, G., Milloy, M., Balneaves, L. G., Simo, A., Guillemi, S. A., Hogg, R. S., Montaner, J. S. G., Wood, E., & Kerr, T. H. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0847-3 · Cited by 49
Jenny, M., Schroecksnadel, S., Überall, F., & Fuchs, D. (2010) · Pharmaceuticals · doi:10.3390/ph3082647 · Cited by 50
Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis
Kellert, B., Nguyen, M. C., Nguyen, C., Nguyen, Q. H., & Wagner, E. J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.001 · Cited by 45
Morgan, E., Khanna, A. S., Skaathun, B., Michaels, S., Young, L. E., Duvoisin, R., Chang, M., Voisin, D. R., Cornwell, B. T., Coombs, R. W., et al. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1197265 · Cited by 44
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Graczyk, M., Łukowicz, M., & Dzierżanowski, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620073 · Cited by 45
Kipp, A. M., Rebeiro, P. F., Shepherd, B. E., Brinkley‐Rubinstein, L., Turner, M. M., Bebawy, S. S., Sterling, T. R., & Hulgan, T. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1716-7 · Cited by 41
Gamble‐George, J., Conger, J. R., Hartley, N. D., Gupta, P., Sumislawski, J. J., & Patel, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3042-8 · Cited by 41
Cannabinoid-induced hyperphagia: Correlation with inhibition of proopiomelanocortin neurons?
Ho, J., Cox, J. M., & Wagner, E. J. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.04.028 · Cited by 37
Sex differences in the cannabinoid regulation of energy homeostasis
Farhang, B., Diaz, S. V., Tang, S. L., & Wagner, E. J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.007 · Cited by 37
Munawar, N., Oriowo, M. A., & Masocha, W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00136 · Cited by 36
Mlost, J., Wąsik, A., & Starowicz, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.029 · Cited by 38
Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37
A Proteomic View of Cellular and Molecular Effects of Cannabis
Abyadeh, M., Gupta, V., Paulo, J. A., Gupta, V. B., Chitranshi, N., Godinez, A., Saks, D., Hasan, M. T., Amirkhani, A., McKay, M. J., et al. (2021) · Biomolecules · doi:10.3390/biom11101411 · Cited by 35
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
Treatment Considerations in Painful HIV-Related Neuropathy
Smith, H. S. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e505 · Cited by 42
Borgquist, A., Meza, C., & Wagner, E. J. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00421.2014 · Cited by 33
Lake, S., Kerr, T. H., Capler, R., Shoveller, J., Montaner, J. S. G., & Milloy, M. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.02.009 · Cited by 33
Unhealthy behaviours for self-management of HIV-related peripheral neuropathy
Nicholas, P. K., Voss, J. G., Corless, I. B., Lindgren, T. G., Wantland, D. J., Kemppainen, J. K., Canaval, G. E., Sefcik, E. F., Nokes, K. M., Bain, C. A., et al. (2007) · AIDS Care · doi:10.1080/09540120701408928 · Cited by 32
Peball, M., Werkmann, M., Ellmerer, P., Stolz, R., Valent, D., Knaus, H., Ulmer, H., Djamshidian, A., Poewe, W. H., & Seppi, K. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02021-z · Cited by 31
Kostanda, E., & Khatib, S. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.114331 · Cited by 31
Neuroimmunity, Drugs of Abuse, and neuroAIDS
Burdo, T. H., Katner, S. N., Taffe, M. A., & Fox, H. S. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9001-3 · Cited by 31
Skalski, L. M., Towe, S. L., Sikkema, K. J., & Meade, C. S. (2017) · Current Drug Abuse Reviews · doi:10.2174/1874473709666160502124503 · Cited by 30
Carey, L. M., Xu, Z., Rajic, G., Makriyannis, A., Romero, J., Hillard, C. J., Mackie, K., & Hohmann, A. G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106560 · Cited by 30
Alternatives to Atypical Antipsychotics for the Management of Dementia-Related Agitation
Passmore, M. J., Gardner, D. M., Polak, Y., & Rabheru, K. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00003 · Cited by 31
Herbst, J., & Musgrave, G. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.09.023 · Cited by 31
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Qian, L., Beers, J. L., Jackson, K. D., & Zhou, Z. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040484 · Cited by 30
The role of cannabinoids in pain control: the good, the bad, and the ugly
Pergolizzi, J. V., LeQuang, J. A., Taylor, R., Raffa, R. B., & Colucci, D. R. (2018) · Minerva Anestesiologica · doi:10.23736/s0375-9393.18.12287-5 · Cited by 30
Tsao, J. C. I., Stein, J. A., Ostrow, D. G., Stall, R. D., & Plankey, M. W. (2011) · Pain · doi:10.1016/j.pain.2011.08.024 · Cited by 28
Mannes, Z. L., Burrell, L. E., Ferguson, E. G., Zhou, Z. H., Lu, H., Somboonwit, C., Cook, R. L., & Ennis, N. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s167826 · Cited by 28
Benefits, toxicity and current market of cannabidiol in edibles
Astray, G., Mejuto, J. C., Xiao, J., & Simal‐Gándara, J. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2024493 · Cited by 30
Washburn, N., Borgquist, A., Wang, K., Jeffery, G. S., Kelly, M. J., & Wagner, E. J. (2012) · Neuroendocrinology · doi:10.1159/000338669 · Cited by 27
Okafor, C. N., Cook, R. L., Chen, X., Surkan, P. J., Becker, J. T., SHOPTAW, S. J., Martin, E. M., & Plankey, M. W. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1245738 · Cited by 24
Aly, E., & Masocha, W. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.01.004 · Cited by 22
Neuroimaging the Neuropathogenesis of HIV
Boerwinkle, A. H., Meeker, K. L., Luckett, P. H., & Ances, B. M. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00548-z · Cited by 22
Skalski, L. M., Towe, S. L., Sikkema, K. J., & Meade, C. S. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1898-z · Cited by 21
Molina, P. E., Amedee, A. M., Winsauer, P. J., Nelson, S., Bagby, G., & Simon, L. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9599-8 · Cited by 20
Wardell, J. D., Shuper, P. A., & Hendershot, C. S. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.026 · Cited by 20
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances
Smith, P. F. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.9.1157 · Cited by 20
Amedee, A. M., Nichols, W. A., LeCapitaine, N. J., Stouwe, C. V., Birke, L. L., Lacour, N., Winsauer, P. J., & Molina, P. E. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0108 · Cited by 19
Metadata
- Authors
- Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A.
- Affiliations
- Imperial College London (GB)
- Chelsea and Westminster Hospital (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- ORCID
- Barton, Simon
- Venue
- Journal of Pain and Symptom Management
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 29
- Issue
- 4
- Pages
- 358-367
- ISSN
- 0885-3924 (ISSN-L)
- OpenAlex
- W2115233771
- Cited by
- 208
- References
- 37
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 4 · 2023: 21 · 2022: 12 · 2021: 18 · 2020: 5 · 2019: 11 · 2018: 8 · 2017: 10 · 2016: 9 · 2015: 15 · 2014: 11 · 2013: 7 · 2012: 9
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Pain and Symptom Management (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- cannabis use, HIV infection, symptom management, neuropathic pain, neuropathy, appetite, nausea, anxiety, depression, paresthesia, antiretroviral therapy adverse effects, memory impairment
- MeSH terms
- Adult, Aged, Cannabinoids, Cannabis, Cross-Sectional Studies, Data Collection, Drug Therapy, Female, United Kingdom, Humans, Male, Phytotherapy, Middle Aged, Nausea, Pain, Severity of Illness Index, HIV Infections, Comorbidity, Plant Preparations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review